Paul Conkling
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Immunology top 10%
- Epidemiology top 10%
- Co-authors
- Donald RichardsRobert M. JotteMatthew D. GalskyMarkus F. RenschlerJennifer OliverCraig H. ReynoldsJames F. FitzgibbonsLeonard M. Klein
- Topics
- Lung Cancer Research Studies (23 papers)Lung Cancer Treatments and Mutations (21 papers)Cancer Immunotherapy and Biomarkers (18 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Paul Conkling
92 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 82
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 656
- Molecular Biology 523
- Immunology 305
- Epidemiology 284
Countries citing papers authored by Paul Conkling
This map shows the geographic impact of Paul Conkling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Conkling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Conkling more than expected).
Fields of papers citing papers by Paul Conkling
This network shows the impact of papers produced by Paul Conkling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Conkling. The network helps show where Paul Conkling may publish in the future.
Co-authorship network of co-authors of Paul Conkling
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Conkling. A scholar is included among the top collaborators of Paul Conkling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Conkling. Paul Conkling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 54 | |
| 7 | 67 | |
| 8 | 13 | |
| 9 | 1 | |
| 10 | 15 | |
| 11 | 8 | |
| 12 | 132 | |
| 13 | 4 | |
| 14 | 28 | |
| 15 | 8 | |
| 16 | 3 | |
| 17 | 58 | |
| 18 | 58 | |
| 19 | 9 | |
| 20 | 3 |
About Paul Conkling
Paul Conkling is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 97 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (23 papers), Lung Cancer Treatments and Mutations (21 papers) and Cancer Immunotherapy and Biomarkers (18 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (656 citations) and Hematology (170 citations). Paul Conkling has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Donald Richards, Robert M. Jotte, Matthew D. Galsky, Markus F. Renschler, Jennifer Oliver, Craig H. Reynolds, James F. Fitzgibbons, Leonard M. Klein, Carol O’Hear and Joachim von Pawel. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.